Orexigen (OREX +3.4% to $5.71) prices an offering of 11M shares at $5.50, just below yesterday's...


Orexigen (OREX +3.4% to $5.71) prices an offering of 11M shares at $5.50, just below yesterday's close of $5.52. Net proceeds will be $56.5M, while there's also a greenshoe option of 1.65M shares. The offering comes just days after Orexigen said the FDA supports speeding up the application for weight loss pill Contrave.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs